Pathology

Department Development History: The Department of Pathology of China-Japan Friendship Hospital was established in 1984 and has now developed into an important department integrating medical care, education, and research. The Department of Pathology undertakes routine pathological diagnosis for the entire hospital, rapid intraoperative pathological diagnosis, cytological diagnosis, and molecular pathological diagnosis, and also undertakes remote pathology consultation tasks for the National Health Commission and the hospital; in 2011, it became a Beijing pathology resident physician training base; in 2014, it became a major department of the Beijing Key Laboratory for the Prevention and Treatment of Allergic Diseases. In 2019, the China-Japan Friendship Hospital Pathology Specialty Medical Alliance was established, currently with more than 40 member units; it was rated as the Genetic and Molecular Pathology Laboratory of the Precision Medicine Center and a PQCC demonstration laboratory. In 2020, it became the chair unit of the Lymphohematopoietic System Group, the deputy chair unit of the Bone and Soft-Tissue System Group, and the deputy chair unit of the Head and Neck System Group of the Pathology Branch of the Beijing Medical Association.

Department Personnel Composition: The department director is Zhong Dingrong. The department currently has 1 chief physician, 4 associate chief physicians, 13 attending physicians, 5 resident physicians, 20 technicians, and 1 researcher. Among them, 17 hold doctoral degrees, 9 hold master’s degrees, and 15 hold bachelor’s degrees. The first director was Professor Wang Tailing, who received the title of Advanced Individual in the Women’s Merit Campaign from the National Health Commission in 1994. He presided over or participated in multiple major national scientific research projects and successively formulated pathological grading and staging standards for chronic hepatitis aligned with international standards, as well as pathological diagnostic standards for severe hepatitis, fatty liver, alcoholic liver disease, and others, for China’s Plan for the Prevention and Treatment of Hepatitis. He successively received 14 awards, including the First, Second, and Third Prizes of the National Science and Technology Progress Award, the First, Second, and Third Prizes of the Ministry of Health Science and Technology Progress Award, and in recent years the Second Prize of the Chinese Medical Science and Technology Award. The current director, Professor Zhong Dingrong, also serves as President of the Beijing Society for Precision Diagnosis of Tumor Pathology; Standing Committee Member and Secretary-General of the Pathology Branch of the China International Exchange and Promotive Association for Medical and Health Care; Chair of the Pathology Diagnosis Expert Committee and Deputy Chair of the Lung Cancer Expert Committee of the National Telemedicine and Internet Medical Center; Standing Committee Member of the 10th Committee of the Pathology Branch of the Beijing Medical Association; Deputy Director of the Pathology Diagnosis Quality Control Center of the Tibet Autonomous Region Medical Association; and specializes in the pathological diagnosis of various tumors, with lymphoma, bone and soft-tissue tumors, and central nervous system tumors as subspecialty areas of expertise.

Outpatient and Ward Facilities: The department is equipped with a routine technology laboratory, a frozen-section and diagnostic room, an immunohistochemistry laboratory, a cytology preparation and diagnostic room, a multidisciplinary discussion and difficult-disease consultation slide-reading room, a molecular pathology room (2 standardized PCR laboratories, 8 rooms in total), 1 cell culture room, and a flow cytometry platform being launched.

Introduction to Diagnostic and Treatment Equipment: The department has 7 multi-head optical microscopes, 24 binocular optical microscopes, 1 digital slide image scanner, 2 cryostats, 3 automated routine pathology processing devices, 9 microtomes, 4 cell processors, 1 electron microscope, 8 automated immunohistochemistry staining machines, 2 special staining machines, 4 real-time quantitative PCR instruments, 1 first-generation sequencer, 2 second-generation sequencers, and others.

Department Diagnostic and Treatment Features: The department performs nearly 90,000 external examination cases annually, more than 7,000 rapid intraoperative pathological diagnoses, more than 12,000 cytological examinations, and more than 35,000 molecular tests.

Featured Service Projects: Tumor molecular pathology testing and HP molecular typing testing.

Professor Zhong Dingrong specializes in the pathological diagnosis of various tumors, with lymphoma, bone and soft-tissue tumors, and central nervous system tumors as subspecialty areas of expertise.

Professor Luo Jie specializes in the pathological diagnosis and research of neuroendocrine tumors.

Professor Tong Jie specializes in pathological diagnosis and treatment research in thyroid pathology, dermatopathology, and other areas.

Scientific Research Achievements of the Department: The department participated in formulating China’s Plan for the Prevention and Treatment of Hepatitis, clarified pathological grading and staging standards for chronic hepatitis aligned with international standards, and pathological diagnostic standards for severe hepatitis, fatty liver, alcoholic liver disease, and others. It successively received 14 national-level awards, including the First, Second, and Third Prizes of the science and technology progress awards of the state, the Ministry of Health, the province, and Beijing. From 2002 to 2006, it completed the pathology subproject of the major scientific research project of the Beijing Municipal Commission of Science and Technology, Integrated Clinical-Pathological Study of Chronic Hepatitis, and other scientific research projects, receiving the First Prize of the Beijing Municipal Commission of Science and Technology Science and Technology Progress Award and the Second Prize of the Chinese Medical Science and Technology Award. The department also undertakes multiple national-level, provincial/ministerial-level, and hospital-level scientific research projects, including a subproject of the National 863 major project, Molecular Typing and Diagnosis and Treatment of Lung Cancer, and Research and Application of Human Stem Cells for the Treatment of Major Diseases. It continuously undertakes the national continuing education project course Pathological Diagnosis of Thoracic Tumors in China.

Department Teaching: Daily teaching activities are rich and varied, including one resident physician theory lecture and slide-reading teaching session each week, one professional study session on new developments each week, two department difficult-case slide-reading sessions each week, and regular professional lectures hosted by experts from outside the hospital and overseas. In 2011, the Department of Pathology became a Beijing standardized resident physician training base. To date, 20 first-stage resident physicians have graduated, and 9 first-stage resident physicians are in training. Resident training management is standardized, requirements are strict, benefits are generous, and the pass rate for stage examinations is high. The department accepts visiting physicians from all over the country for study, with training covering routine pathology, frozen pathology, liver biopsy pathology, cytology, and molecular pathology. There is currently 1 doctoral/master’s supervisor and 10 enrolled graduate students.

Department Honors: Professor Wang Tailing successively received the First, Second, and Third Prizes of the National Science and Technology Progress Award, the First, Second, and Third Prizes of the Ministry of Health Science and Technology Progress Award, and in recent years the Second Prize of the Chinese Medical Science and Technology Award, for a total of 14 awards. In 1994, he received the title of Advanced Individual in the Women’s Merit Campaign from the Ministry of Health. Due to his outstanding contributions to the field of liver disease pathology, the Hepatology Branch of the Chinese Medical Association awarded him the Lifetime Contribution Award in September 2014. In 2015, the Pathology Branch of the Chinese Medical Association awarded him the title of Expert with Outstanding Contributions to the Chinese Pathology Cause. In October 2020, the Pathology Branch of the Chinese Medical Association awarded him the honorary title of 2020 Chinese Pathology Cause Lifetime Achievement Expert. In December 2020, he received the Life’s Dignity Award at the Respecting Life, Honoring Physicians event.

From 2020 to 2021, the Party Branch of the Department of Pathology received the honor of Advanced Primary-Level Party Organization of China-Japan Friendship Hospital, and Professor Zhong Dingrong, Director of the Department of Pathology and Party Branch Secretary, received the honor of Outstanding Party Affairs Worker of the Organs Directly Affiliated with the National Health Commission.

Location Within the Hospital: The department’s outpatient clinic is located on the 1st floor of the Surgical Building

Department Telephone: Outpatient: 010-84205474